STOCK TITAN
  1. Home
  2. News
  3. WVE

Wave Life Sciences Ltd. - WVE STOCK NEWS

IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences Provides Update on Phase 1b/2a PRECISION-HD Trials
clinical trial
IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences to Present at the Third Annual Stifel CNS Day
conferences
IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
earnings
IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021
conferences earnings
IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference  
conferences
IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences Highlights Pipeline Progress and Expansion Leveraging New PN Backbone Chemistry Modifications
IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences Announces Appointment of Jonathan Rosin as Chief Human Resources Officer
management
IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences to Present at the 29th Annual Credit Suisse Healthcare Conference
conferences
IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences Reports Third Quarter 2020 Financial Results and Provides Business Update
earnings
IMPACT
SENTIMENT
WVE : Nasdaq
Wave Life Sciences to Webcast Conference Call of Third Quarter 2020 Financial Results on November 9, 2020
conferences earnings
Stock WVE logo
Wave Life Sciences Ltd.

Nasdaq:WVE

WVE Rankings

#3558 Ranked by Market Cap
#1217 Ranked by Stock Gains
N/A Ranked by Dividends

WVE Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Singapore
7 Straits View

About WVE

wave life sciences ltd. (nasdaq: wve) is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment options for patients. given the unique versatility of its chemistry platform, wave’s pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded rnai.